Patents Assigned to Sequana Medical AG
  • Patent number: 9039652
    Abstract: A fluid management system for the treatment of ascites, pleural effusion or pericardial effusion is provided including an implantable device including a pump, control circuitry, battery and transceiver; a charging and communication system configured to periodically charge the battery and communicate with the implantable device to retrieve performance data; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The implantable device includes a number of features that provide automated movement of fluid to the bladder with reduced risk of clogging, with no patient involvement other than occasional recharging of the battery of the implantable device. The monitoring and control software is available only to the treating physician, such that the physician interacts with the implantable device via the charging and communication system.
    Type: Grant
    Filed: February 15, 2012
    Date of Patent: May 26, 2015
    Assignee: SEQUANA MEDICAL AG
    Inventors: Thomas Werner Degen, Daniel Thomas Thommen, Noel L. Johnson
  • Patent number: 8882699
    Abstract: An implantable fluid management device, designed to drain excess fluid from a variety of locations in a living host into a second location within the host, such as the bladder of that host. The device may be used to treat ascites, chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, pulmonary edema, or any fluid collection within the body of a human, or a non-human mammal.
    Type: Grant
    Filed: August 22, 2013
    Date of Patent: November 11, 2014
    Assignee: Sequana Medical AG
    Inventor: Daniel R. Burnett
  • Publication number: 20140266022
    Abstract: Systems and methods are provided for regulating the transfer of energy inductively between an implantable device and an external charging system, wherein the energy transfer rate is regulated by varying an operating frequency of an inductive energy transfer circuit of the implantable device responsive a temperature measured within the implantable device.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: SEQUANA MEDICAL AG
    Inventors: Thomas Werner DEGEN, Stefan TSCHUMPER
  • Publication number: 20140200481
    Abstract: A system for noninvasively monitoring cancerous cells within bodily fluid accumulated due to ascites, pleural effusion or pericardial effusion is provided including an implantable pump having control circuitry; a charging and communication system configured to periodically charge and communicate with the implantable pump to retrieve performance data; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable pump and charging and communication system. The implantable pump is configured to move fluid containing cancerous cells from a body cavity to the bladder such that the fluid may be excreted during urination, collected and analyzed with an analysis station to assess progress of the cancer or efficacy of a cancer treatment program.
    Type: Application
    Filed: January 14, 2014
    Publication date: July 17, 2014
    Applicant: SEQUANA MEDICAL AG
    Inventors: Noel L. Johnson, Steve Whittaker
  • Patent number: 8771221
    Abstract: A device for removing fluid from a first bodily cavity and for directing that fluid into a second bodily cavity while avoiding risks of infection and, in one embodiment, excessive dehydration of the first bodily cavity. The device includes an uptake tube having a proximal end in fluid communication with the first bodily cavity and a distal end in fluid communication with a pump, and an outflow tube having a proximal end in fluid communication with the pump and a distal end in fluid communication with the second bodily cavity. The distal end of the uptake tube may be coupled to a reservoir configured to expand upon ingression of fluid into the reservoir and to contract upon removal of fluid due to a negative pressure provided by the pump.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: July 8, 2014
    Assignee: Sequana Medical AG
    Inventor: Daniel R. Burnett
  • Publication number: 20140121590
    Abstract: Under one aspect of the present invention, a catheter includes an elongate member; a plurality of septa configured to define a plurality of lumens along the elongate member; and a plurality of slits defined through the elongate member, each slit configured to provide fluidic communication between an environment about the catheter and a corresponding lumen of the plurality of lumens, at least one slit having a different length than at least one other slit.
    Type: Application
    Filed: October 31, 2012
    Publication date: May 1, 2014
    Applicant: Sequana Medical AG
    Inventor: Thomas DEGEN
  • Publication number: 20140066841
    Abstract: An artificial liver system for treating liver failure includes a reservoir to provide albumin-containing dialysis fluid to the patient's peritoneum, an implantable device including a pump to pump the fluid from the peritoneum to the bladder via respective catheters, control circuitry, battery and transceiver; a charging and communication system configured to periodically charge the battery and communicate with the implantable device to retrieve data reflective of the patient's health; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The monitoring and control software allows a treating physician to remotely adjust the volume, time, and frequency with which fluid is pumped from the peritoneal cavity to the bladder based on the data reflective of the patient's health.
    Type: Application
    Filed: November 11, 2013
    Publication date: March 6, 2014
    Applicant: Sequana Medical AG
    Inventors: Thomas Werner Degen, Daniel Thomas Thommen, Noel L. Johnson
  • Publication number: 20130338565
    Abstract: An implantable fluid management device, designed to drain excess fluid from a variety of locations in a living host into a second location within the host, such as the bladder of that host. The device may be used to treat ascites, chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, pulmonary edema, or any fluid collection within the body of a human, or a non-human mammal.
    Type: Application
    Filed: August 22, 2013
    Publication date: December 19, 2013
    Applicant: Sequana Medical AG
    Inventor: Daniel R. Burnett
  • Publication number: 20130338566
    Abstract: An implantable fluid management device, designed to drain excess fluid from a variety of locations in a living host into a second location within the host, such as the bladder of that host. The device may be used to treat ascites, chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, pulmonary edema, or any fluid collection within the body of a human, or a non-human mammal.
    Type: Application
    Filed: August 22, 2013
    Publication date: December 19, 2013
    Applicant: Sequana Medical AG
    Inventor: Daniel R. Burnett
  • Patent number: 8585635
    Abstract: An artificial liver system for treating liver failure includes a reservoir to provide albumin-containing dialysis fluid to the patient's peritoneum, an implantable device including a pump to pump the fluid from the peritoneum to the bladder via respective catheters, control circuitry, battery and transceiver; a charging and communication system configured to periodically charge the battery and communicate with the implantable device to retrieve data reflective of the patient's health; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The monitoring and control software allows a treating physician to remotely adjust the volume, time, and frequency with which fluid is pumped from the peritoneal cavity to the bladder based on the data reflective of the patient's health.
    Type: Grant
    Filed: February 15, 2012
    Date of Patent: November 19, 2013
    Assignee: Sequana Medical AG
    Inventors: Thomas Werner Degen, Daniel Thomas Thommen, Noel L. Johnson
  • Publication number: 20130253409
    Abstract: A device for removing fluid from a first bodily cavity and for directing that fluid into a second bodily cavity while avoiding risks of infection and, in one embodiment, excessive dehydration of the first bodily cavity. The device includes an uptake tube having a proximal end in fluid communication with the first bodily cavity and a distal end in fluid communication with a pump, and an outflow tube having a proximal end in fluid communication with the pump and a distal end in fluid communication with the second bodily cavity. The distal end of the uptake tube may be coupled to a reservoir configured to expand upon ingression of fluid into the reservoir and to contract upon removal of fluid due to a negative pressure provided by the pump.
    Type: Application
    Filed: March 7, 2013
    Publication date: September 26, 2013
    Applicant: Sequana Medical AG
    Inventor: Daniel R. Burnett
  • Patent number: 8517973
    Abstract: An implantable fluid management device, designed to drain excess fluid from a variety of locations in a living host into a second location within the host, such as the bladder of that host. The device may be used to treat ascites, chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, pulmonary edema, or any fluid collection within the body of a human, or a non-human mammal.
    Type: Grant
    Filed: February 16, 2011
    Date of Patent: August 27, 2013
    Assignee: Sequana Medical AG
    Inventor: Daniel R. Burnett
  • Patent number: 8398577
    Abstract: A device for removing fluid from a first bodily cavity and for directing that fluid into a second bodily cavity while avoiding risks of infection and, in one embodiment, excessive dehydration of the first bodily cavity. The device includes an uptake tube having a proximal end in fluid communication with the first bodily cavity and a distal end in fluid communication with a pump, and an outflow tube having a proximal end in fluid communication with the pump and a distal end in fluid communication with the second bodily cavity. The distal end of the uptake tube may be coupled to a reservoir configured to expand upon ingression of fluid into the reservoir and to contract upon removal of fluid due to a negative pressure provided by the pump.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: March 19, 2013
    Assignee: Sequana Medical AG
    Inventor: Daniel R. Burnett
  • Patent number: 8394048
    Abstract: A transvesicular drainage device configured to drain excess fluid from a variety of locations in the human body into the bladder. The device may be used to treat ascites or any fluid collection within the body of a human or of a non-human mammal.
    Type: Grant
    Filed: January 15, 2008
    Date of Patent: March 12, 2013
    Assignee: Sequana Medical AG
    Inventor: Daniel Rogers Burnett
  • Patent number: 8202248
    Abstract: A device and methods for treating renal failure are disclosed. One embodiment of the device is an implantable peritoneal dialysis device. When in use, the device can have a semi-permeable reservoir implanted in the peritoneal cavity. The reservoir can receive blood waste and drain through one or more conduits, via a pump, to the biological bladder. Solids and/or a solution benefiting dialysis can be pumped to the reservoir and/or implanted in the peritoneal cavity.
    Type: Grant
    Filed: August 18, 2004
    Date of Patent: June 19, 2012
    Assignee: Sequana Medical AG
    Inventors: Daniel R. Burnett, Gregory W. Hall